Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 88.16M
0.62%0.68%32.11x19.37x11.73x24.06x24.63x 983B
2.31%2.41%24.72x6.22x5.7x15.5x17.14x 557B
3.01%3.15%28.55x-837.28x6.84x14.01x14.38x 406B
3.14%3.22%16.98x6.3x4.23x10.4x11.73x 314B
1.89%2%22.08x5.14x4.62x13.09x13.77x 273B
3.01%3.09%20.6x6.18x5.34x12.96x14.15x 272B
3.78%3.69%13.31x5.75x4.94x10.16x11.87x 203B
2.93%3.09%22.41x16.71x6.02x10.5x13.77x 186B
2.6%2.66%-44.74x8.48x5.4x29.79x59.82x 155B
6.99%6.96%11.73x1.63x3.1x7.55x8.78x 143B
-.--%-.--%26.69x5.36x8.11x18.28x19.03x 118B
4.6%4.73%10.72x4.74x2.96x7.92x8.61x 112B
5.87%6.22%10.78x1.16x2.08x6.71x7.63x 99.57B
3.64%3.81%12.36x4.45x2.69x7.92x8.93x 102B
1.82%2.08%24.33x5.51x8.26x15.62x16.34x 76.7B
4.11%4.19%40.5x1.05x2.54x9.35x25.89x 48.69B
0.55%0.62%35.09x4.74x7.8x26.03x28.67x 48.18B
0.58%1.94%16.22x1.33x1.52x7.21x11.99x 42.93B
Average 2.86% 3.03% 18.02x -40.73x 5.22x 13.73x 17.62x 217.96B
Weighted average by Cap. 2.42% 2.52% 21.35x -73.50x 6.74x 15.89x 18.28x
Other Pharmaceuticals
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!